Provided by Sibel Yilmaz
Sibel Yilmaz advises on all aspects of competition law, foreign investment and foreign subsidies screening, with a focus on the life sciences, technology and private equity sectors.
Sibel has particular expertise in the life sciences sector and has been involved in some of the industry's most high profile matters in recent years, including representing Novartis on its $30 billion acquisition of GSK’s oncology business, advising Takeda on its sale of certain respiratory products to AstraZeneca and representing clients in several investigations relating to alleged excessive prices and other non-competitive practices in the life science sector.
Provided by Chambers
Sibel Yilmaz has experience in the notification of mergers and foreign direct investments, and is able to assist clients with compliance-related questions. She demonstrates particular understanding of the life sciences sector.
Provided by Chambers
Sibel Yilmaz is a standout regulatory lawyer who has become my go-to for global antitrust advice.
She has both a strategic and commercial mindset.
Sibel Yilmaz is a standout regulatory lawyer who has become my go-to for global antitrust advice.
She has both a strategic and commercial mindset.
